Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
63.44
-1.94 (-2.97%)
At close: Jul 10, 2026, 4:00 PM EDT
63.50
+0.06 (0.09%)
After-hours: Jul 10, 2026, 7:55 PM EDT
KNSA Market Cap
KNSA has a market cap or net worth of $4.88 billion as of July 10, 2026. Its market cap has increased by 135.69% in one year.
Market Cap
4.88B
Enterprise Value
4.42B
1-Year Change
135.69%
Ranking
Category
Stock Price
$63.44
Market Cap Chart
Since May 24, 2018, KNSA's market cap has increased from $914.40M to $4.88B, an increase of 433.79%. That is a compound annual growth rate of 22.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 4.88B | 56.11% |
| Dec 31, 2025 | 3.13B | 118.93% |
| Dec 31, 2024 | 1.43B | 15.76% |
| Dec 29, 2023 | 1.23B | 18.44% |
| Dec 30, 2022 | 1.04B | 28.47% |
| Dec 31, 2021 | 810.80M | -32.60% |
| Dec 31, 2020 | 1.20B | 98.17% |
| Dec 31, 2019 | 607.00M | -56.32% |
| Dec 31, 2018 | 1.39B | 51.96% |
| May 24, 2018 | 914.40M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dr. Reddy's Laboratories | 10.87B |
| Alkermes | 8.66B |
| Hims & Hers Health | 7.96B |
| Liquidia | 6.93B |
| Lantheus Holdings | 6.88B |
| Amneal Pharmaceuticals | 5.43B |
| Indivior Pharmaceuticals | 4.94B |
| Regencell Bioscience Holdings | 2.91B |